Seòmar agus comataidhean

Three Rapid Cancer Diagnostic Services (RCDS) – formerly known as Early Cancer Diagnostic Centres (ECDC) – have been opened in NHS Ayrshire and Arran, NHS Dumfries and Galloway and NHS Fife. An interim report on the rollout of RCDC's is expected shortly and are actively considering further rollout of Rapid Cancer Diagnostic Services.

All Boards have recruited both medical and non-medical staff to manage the new referral pathway for patients with non-specific symptoms, including navigators who support patients from the point of referral.

Recruitment for clinical services is the responsibility of individual Boards and it is therefore for them to provide specific details.

The University of Strathclyde has been commissioned to undertake critical evaluation of early adopter sites to inform wider roll-out, ensuring learnings from the first three Services are embedded, working towards equitable access across NHS Scotland, as set out in the NHS Recovery Plan.

In the meantime, officials are working with Boards to open additional early adopter sites.

Recruitment will be undertaken by the host Board, and will be dependent on their locally agreed pathway and resourcing requirements.

£10 million of funding has been directed to support Cancer Waiting Times improvements in our NHS across 2022-23. Significant funds are going towards up-skilling nurses and investing in diagnostic tests to support extended working days/weekend working to increase capacity.

Meanwhile, work is underway to develop Scotland’s new cancer strategy, expected to publish Spring 2023. A recent public consultation received over 250 responses, including from blood cancer charities. A series of workshops are planned throughout September to help gain further insight and hear directly from those with lived experience to inform the focus of this strategy.

NHS Boards received notification on the 11 August of their share of the £50 million investment which has been allocated in its entirety to support NHS Health Boards to improve A&E waits through a new National Collaborative for Urgent and Unscheduled Care.

Each board’s share of the £50 million fund is listed below:

Rapid Cancer Diagnostic Services (RCDS) – formerly known as Early Cancer Diagnostic Centres (ECDC) – are fast-track diagnostic pathways taking patients from referral to diagnosis, not treatment.

Scotland’s first three RCDS are early adopters to help inform wider roll-out of an optimal model for patients with non-specific symptoms suspicious of cancer.

All three Services are using a nationally agreed minimum data-set, capturing consistent data from age, gender, symptoms at presentation etc. A sub-section of this data will be published by the three Boards in 2022.

Meanwhile, work is underway with Public Health Scotland to scope and progress national data collection as more sites are expected to be established.

The Scottish Government remains committed to supporting and growing our nursing and midwifery workforce. That is why student nurses and midwives entering Scottish Government funded degree programmes will increase by 8.7% in 2022-23, to a total recommended target intake of 4837 nursing and midwifery students.

Universities are continuing their recruitment for programmes commencing in the 2022-23 academic year. Final data on the number of placed applicants on nursing and midwifery programmes commencing in the 2022-23 academic year will not be available until January 2023.

Three Rapid Cancer Diagnostic Services (RCDS), formerly known as Early Cancer Diagnostic Centres (ECDC), have been established in NHS Scotland, and we are committed to ensuring equitable access across the country.

RCDS’s provide primary care with a new referral route for patients with non-specific symptoms suspicious of cancer (i.e. weight loss, fatigue, nausea), which can often be a sign of blood cancer. The Clinical Leads for two of the Services are Haematologists, reflecting the role that this new model can play in diagnosing blood cancers earlier.

Our NHS Recovery Plan commits to providing greater public awareness of signs and symptoms of cancer, with a new national campaign in development and website being re-designed.

The Scottish Government will continue to work closely with primary care clinicians, including the Scottish Primary Care Cancer Group, to identify possible symptoms as early as possible and support appropriate referral via the Scottish Referral Guidelines for Suspected Cancer.

The Scottish Government has had very constructive discussions with AstraZeneca on Evusheld ® for the preventative treatments for COVID-19. However, throughout the pandemic, a UK-wide approach to the procurement of therapeutics has been taken and has proven vital to allow the UK to have the buying power to secure significant numbers of therapeutics in a competitive global market. A UK-wide approach has also been taken on the development and implementation of clinical prescribing policies for COVID-19 therapeutics. This has ensured patients across the UK have had equal access to safe and effective medicines for COVID-19.

My intention is to update Parliament with our Winter Resilience plans and publish our Winter Resilience Overview, covering both the NHS and Social Care, early next month, subject to discussions at Parliamentary Bureau. Caroline Lamb, CEO of NHS Scotland has also already written to NHS Boards and Integration Authorities regarding winter resilience plans at a national level and setting out clear expectations for local resilience and response.

I refer the member to the answer to question S6W-10433 on 20 September 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers